HYDI
Hydromer, Inc. invents, develops, patents, licenses, manufactures, and sells hydrophilic polymer-based products and services in the United States and internationally. The company operates in two segments, Polymer Research and Medical Products. It offers medical coatings and services; medical hydrogel; cosmetic intermediaries; and anti-fog/anti-frost condensation control coating products. The company also provides cosmetics and personal care products, and watercraft hulls coating products; and engineering and contract coating services. It serves the medical, cosmetics, animal health, and industrial fields. Hydromer, Inc. was founded in 1980 and is based in Branchburg, New Jersey.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2024 Q1 | 0.02 | $788,000 | — |
| 2023 Q3 | -0.00 | $1M | $288,418 |
| 2022 Q2 | -0.09 | $847,600 | $62,733 |
| 2022 Q1 | -0.05 | $1M | -$71,163 |
| 2022 Q4 | -0.05 | $1M | -$388,732 |
| 2022 Q3 | -0.02 | $896,781 | $505,985 |
| 2021 Q2 | -0.19 | $743,926 | -$314,781 |
| 2021 Q1 | -0.07 | $1M | -$143,979 |